切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - NADPH Oxidases - Topoisomerases

19件产品中的 1-10

页面
每页
清除全部
  1. GKT137831
    B4763 GKT137831
     1 Citation
    Target: NADPH Oxidases
    Summary: Nox1/Nox4双重抑制剂
      ≥39.5 mg/mL
      insoluble in H2O
  2. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  3. Diphenyleneiodonium chloride
    B6326 Diphenyleneiodonium chloride
    中文名: 二苯基氯化碘盐
    Target: NADPH Oxidases|NOS|GPR3
    Summary: iNOS和eNOS抑制剂,GPR3激动剂
      ≥6.99 mg/mL
      insoluble in H2O
  4. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  5. Apocynin
    B3675 Apocynin
    中文名: 罗布麻宁,夹竹桃麻素,香兰基甲基酮
    Target: NADPH Oxidases
    Summary: 选择性NADPH氧化酶抑制剂
      ≥8.25 mg/mL
  6. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  7. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  8. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  9. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  10. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O

19件产品中的 1-10

页面
每页